Bodor, J. N., Boumber, Y., & Borghaei, H. (2020). Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC). Cancer, 126(2), 260-270. https://doi.org/10.1002/cncr.32468
Chicago Style (17th ed.) CitationBodor, J. Nicholas, Yanis Boumber, and Hossein Borghaei. "Biomarkers for Immune Checkpoint Inhibition in Non–small Cell Lung Cancer (NSCLC)." Cancer 126, no. 2 (2020): 260-270. https://doi.org/10.1002/cncr.32468.
MLA (9th ed.) CitationBodor, J. Nicholas, et al. "Biomarkers for Immune Checkpoint Inhibition in Non–small Cell Lung Cancer (NSCLC)." Cancer, vol. 126, no. 2, 2020, pp. 260-270, https://doi.org/10.1002/cncr.32468.
Warning: These citations may not always be 100% accurate.